Potential of Ravuconazole and its Prodrugs as the New Oral Therapeutics for Onychomycosis.

Autor: Hideyo Yamaguchi1 hyamaguc@main.teikyo-u.ac.jp
Zdroj: Medical Mycology Journal. 2016, Vol. 57 Issue 4, pE93-E110. 18p.
Databáze: Academic Search Ultimate